NCT00002200View on ClinicalTrials.gov

A Study of 1592U89 in HIV-Infected Adults

NACompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Abacavir sulfate

Trial Locations (1)

277093398

Glaxo Wellcome Inc, Research Triangle Park

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Glaxo Wellcome

INDUSTRY

NCT00002200 - A Study of 1592U89 in HIV-Infected Adults | Biotech Hunter | Biotech Hunter